Biology of GDNF and its receptors - Relevance for disorders of the central nervous system. 2017

Carlos F Ibáñez, and Jaan-Olle Andressoo
Department of Physiology, National University of Singapore, Singapore 117597, Singapore; Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore; Department of Neuroscience, Karolinska Institute, Stockholm S-17177, Sweden; Stellenbosch Institute for Advanced Study, Wallenberg Research Centre at Stellenbosch University, Stellenbosch 7600, South Africa. Electronic address: phscfi@nus.edu.sg.

A targeted effort to identify novel neurotrophic factors for midbrain dopaminergic neurons resulted in the isolation of GDNF (glial cell line-derived neurotrophic factor) from the supernatant of a rat glial cell line in 1993. Over two decades and 1200 papers later, the GDNF ligand family and their different receptor systems are now recognized as one of the major neurotrophic networks in the nervous system, important for the development, maintenance and function of a variety of neurons and glial cells. The many ways in which the four members of the GDNF ligand family can signal and function allow these factors to take part in the control of multiple types of processes, from neuronal survival to axon guidance and synapse formation in the developing nervous system, to synaptic function and regenerative responses in the adult. In this review, we will briefly summarize basic aspects of GDNF signaling mechanisms and receptor systems and then review our current knowledge of the physiology of GDNF activities in the central nervous system, with an eye to its relevance for neurodegenerative and neuropsychiatric diseases.

UI MeSH Term Description Entries
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017475 Receptors, Nerve Growth Factor Cell surface receptors that bind NERVE GROWTH FACTOR; (NGF) and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR. NGF Receptors,Nerve Growth Factor Receptors,Neurotrophic Factor Receptor,Neurotrophin Receptor,Receptors, NGF,Receptors, Neurotrophin,Neurotrophin Receptors,Receptors, Neurotrophic Factor,Neurotrophic Factor Receptors,Receptor, Neurotrophic Factor,Receptor, Neurotrophin
D051100 Glial Cell Line-Derived Neurotrophic Factor The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE. Glial Cell-Derived Neurotrophic Factor,Glial-Derived Neurotrophic Factor,GDNF,GDNF Growth Factor,Glial Cell-Line Derived Neurotrophic Factor,Factor, Glial-Derived Neurotrophic,Glial Cell Derived Neurotrophic Factor,Glial Cell Line Derived Neurotrophic Factor,Glial Derived Neurotrophic Factor,Growth Factor, GDNF,Neurotrophic Factor, Glial-Derived

Related Publications

Carlos F Ibáñez, and Jaan-Olle Andressoo
February 1987, Biochemical Society transactions,
Carlos F Ibáñez, and Jaan-Olle Andressoo
January 1982, Progress in neuro-psychopharmacology & biological psychiatry,
Carlos F Ibáñez, and Jaan-Olle Andressoo
April 1997, Expert opinion on investigational drugs,
Carlos F Ibáñez, and Jaan-Olle Andressoo
August 2021, Journal of the neurological sciences,
Carlos F Ibáñez, and Jaan-Olle Andressoo
January 1968, International review of neurobiology,
Carlos F Ibáñez, and Jaan-Olle Andressoo
January 2019, Current pharmaceutical design,
Carlos F Ibáñez, and Jaan-Olle Andressoo
December 2005, Journal of leukocyte biology,
Carlos F Ibáñez, and Jaan-Olle Andressoo
May 2004, Journal of child neurology,
Carlos F Ibáñez, and Jaan-Olle Andressoo
January 2020, Molecular imaging,
Carlos F Ibáñez, and Jaan-Olle Andressoo
January 1984, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!